This study aimed to assess the influence of increment of gantry (IG) value on plan quality among cervical cancer patients treated with volumetric modulated arc therapy (VMAT). Twenty postoperative cervical cancer patients receiving radiotherapy were selected. Four different VMAT plans were designed in Monaco TPS using the same optimization conditions but with varying IG parameters (10°, 20°, 30°, and 40°). The IG10 group did not meet the clinical requirements. The target dose of the IG20 group was slightly worse than that of IG30 and IG40 groups; the differences in dose distribution in organs at risk among the IG20, IG30, and IG40 groups were negligible. The average monitoring units of the IG20, IG30, and IG40 groups were 704.6, 594.6, and 572.6, and the average control points of the three groups were 134.4, 139.4, and 140.3, respectively. The plan delivery times of the three groups were 117.6 s, 111.0 s, and 118.1 s, respectively. At a 3% dose difference and a 3 mm distance to agreement, the gamma pass rates of the IG20, IG30, and IG40 plans were 99.1%, 99.6%, and 99.4%, respectively. Considering the plan quality, the dose accuracy, and delivery efficiency, IG30 is recommended for cervical cancer VMAT planning.